Artiva Biotherapeutics Cash Flow Statement (2023-2025) | ARTV

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -16.66M11.23M-11.39M-13.84M-15.51M-16.49M-16.09M
Depreciation and Depletion 0.60M0.60M0.60M0.60M0.60M0.60M0.60M0.60M0.60M0.60M
Share-based Compensation 1.37M1.39M1.41M1.48M1.91M2.18M2.05M1.55M1.63M
Gains from Sales and Divestitures 0.02M0.05M0.21M
Gains from Investment Securities -0.03M-0.04M-0.03M0.11M0.04M0.03M0.44M
Non-cash Items 0.21M17.31M10.40M1.11M1.17M1.36M
Cash from Operations -10.75M-10.68M-15.09M-13.69M-11.61M-14.65M-19.84M-22.98M-19.20M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.16M0.28M0.37M0.27M0.66M1.04M0.72M0.51M0.36M
Depreciation & Amortization (CF) 0.60M0.56M0.59M0.59M0.60M0.63M0.61M0.63M0.64M0.66M
Change in Working Capital
Change in Receivables -0.08M-0.89M-0.21M-0.25M-0.13M-0.44M0.09M-0.20M0.05M
Change in Account Payables 1.59M-1.92M0.85M-0.95M0.70M-0.08M0.04M-0.21M-0.44M
Change in Accured Expenses -0.36M0.14M-3.04M0.27M3.10M-0.99M-0.93M-0.55M1.12M
Investing Activities
Capital Expenditures 0.18M0.64M0.02M0.46M0.10M0.06M0.88M0.68M0.60M
Change in Acquisitions & Divestments 12.00M12.80M16.00M14.00M12.40M13.95M29.00M28.25M29.62M
Cash from Investing Activities -0.49M-2.67M9.78M1.35M-130.63M-0.97M9.97M21.12M16.28M
Financing Activities
Other financing activities 2.60M0.02M
Change in Capital Stock
Shares Issued 166.49M0.14M
Misc.
Cash from Financing Activities 23.43M0.96M163.87M-0.03M0.24M-0.07M-0.04M
Change in Cash 12.19M-12.38M-5.30M-13.95M21.63M-15.65M-9.63M-1.93M-2.96M
Beginning Cash Balance 53.70M53.70M65.89M53.50M48.20M34.25M55.88M175.63M144.33M125.96M
Free Cash Flow -10.93M-11.31M-15.10M-14.15M-11.71M-14.71M-20.72M-23.67M-19.80M
Net Cash Flow 12.19M-12.38M-5.30M-12.34M21.63M-15.65M-9.63M-1.93M-2.96M